Bharat Biotech’s Covaxin and Covishield vaccine (developed by Oxford University and pharmaceutical company AstraZeneca) have been given approval for emergency use in India by the Drug Control General of India.

It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.
— Narendra Modi (@narendramodi) January 3, 2021

Post-approval, now the government has the task to begin the biggest vaccination drive in the world to ensure that the COVID vaccine reaches everyone in need. And for the same, the government would be relying on the Co-WIN app.

The Co-WIN app is where one can register if they want to get vaccine doses for themselves or their loved ones. Here is everything you need to know about it.

Also Read: Here’re The 10 Worst-Rated Bollywood Movies Of 2020 As Per IMDb

As of now, the Co-WIN app is under construction and will not work if you download it. But it already has the data of frontline workers who will be the first to get the vaccine. Over 75 lakh health officials have registered for it already.

You, as not a frontliner, would be able to register once the app is available on App Store and Play Store.

Once live, the app will show everyone three options for registration including self-registration, individual registration, and bulk upload.

Once registered, you would be either called to vaccination camps to get the vaccine dose or the government might home deliver the same. There is no information in that regard as of now.

The app will also lend an option to report the adverse effects of the vaccine if any. Moreover, an e-certificate, confirming vaccination, will also be provided.

Also Read: Car Price May Go Up As Govt Proposes Mandatory Airbags For Front-Seated Passengers

The Covishield vaccine is likely to cost ₹1,000 per dose when it is available in the open market and for private use. The first 100 million shots of Covishield, which Serum Institute of India (SII) will likely sell to the Indian government, will cost ₹200. A person will have to take two doses of the Covishield vaccine to gain full immunity.